Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Exchange Rates
Interest Rates
Futures
Economy

Biogen PE Ratio 2006-2018 | BIIB

Current and historical p/e ratio for Biogen (BIIB) from 2006 to 2018. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Biogen PE ratio as of November 15, 2018 is 12.79.
Biogen PE Ratio Historical Data
Date Stock Price TTM Net EPS PE Ratio
2018-11-15 321.72 20.80
2018-09-30 353.31 $15.47 22.84
2018-06-30 290.24 $14.11 20.57
2018-03-31 273.82 $14.00 19.56
2017-12-31 318.57 $11.92 26.73
2017-09-30 313.12 $16.31 19.20
2017-06-30 271.36 $15.23 17.82
2017-03-31 273.42 $15.95 17.14
2016-12-31 261.39 $16.92 15.45
2016-09-30 288.53 $17.70 16.30
2016-06-30 222.89 $17.14 13.00
2016-03-31 239.95 $16.28 14.74
2015-12-31 282.37 $15.34 18.41
2015-09-30 268.35 $15.31 17.53
2015-06-30 372.33 $14.78 25.19
2015-03-31 389.19 $13.86 28.08
2014-12-31 312.88 $12.39 25.25
2014-09-30 304.92 $10.57 28.85
2014-06-30 290.63 $9.00 32.29
2014-03-31 281.93 $8.05 35.02
2013-12-31 257.69 $7.82 32.95
2013-09-30 221.92 $7.13 31.12
2013-06-30 198.36 $6.75 29.39
2013-03-31 177.54 $6.30 28.18
2012-12-31 134.91 $5.76 23.42
2012-09-30 137.53 $5.75 23.92
2012-06-30 133.08 $5.51 24.15
2012-03-31 116.14 $5.08 22.86
2011-12-31 101.44 $5.03 20.17
2011-09-30 85.86 $4.80 17.89
2011-06-30 98.55 $4.42 22.30
2011-03-31 67.72 $4.36 15.53
2010-12-31 61.80 $3.96 15.61
2010-09-30 51.73 $4.03 12.84
2010-06-30 43.74 $3.93 11.13
2010-03-31 52.90 $3.30 16.03
2009-12-31 49.31 $3.34 14.76
2009-09-30 46.57 $2.98 15.63
2009-06-30 41.62 $2.73 15.24
2009-03-31 48.32 $2.94 16.43
2008-12-31 43.90 $2.64 16.63
2008-09-30 46.35 $2.61 17.76
2008-06-30 51.52 $2.32 22.21
2008-03-31 56.86 $2.16 26.33
2007-12-31 52.47 $2.00 26.23
2007-09-30 61.14 $1.65 37.05
2007-06-30 49.31 $1.69 29.18
2007-03-31 40.91 $0.65 62.93
2006-12-31 45.34 $0.63 71.97
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $63.175B $12.274B
Biogen is a leading biopharmaceutical company engaged in the research, development and marketing of targeted therapies for the treatment of cancer, autoimmune and inflammatory diseases. The company owns industry leading brands for the treatment of multiple sclerosis, next-generation treatments for hemophilia, and a deep clinical pipeline ranging from Alzheimer's disease, lupus nephritis to neuropathic pain.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $121.301B 13.72
Gilead Sciences (GILD) United States $91.265B 10.99
Celgene (CELG) United States $48.689B 9.45
Illumina (ILMN) United States $45.310B 52.78
Vertex Pharmaceuticals (VRTX) United States $42.060B 73.47
Regeneron Pharmaceuticals (REGN) United States $36.446B 18.49
Alexion Pharmaceuticals (ALXN) United States $25.904B 17.73
BioMarin Pharmaceutical (BMRN) United States $16.339B 0.00
Incyte (INCY) United States $13.652B 377.35
Seattle Genetics (SGEN) United States $8.501B 0.00
Exact Sciences (EXAS) United States $8.413B 0.00
Bio-Rad Laboratories (BIO.B) United States $8.015B 51.25
QIAGEN (QGEN) Netherlands $7.819B 25.01
Sarepta Therapeutics (SRPT) United States $7.484B 0.00
BeiGene (BGNE) Cayman Islands $6.679B 0.00
Alnylam Pharmaceuticals (ALNY) United States $6.574B 0.00
Bluebird Bio (BLUE) United States $6.371B 0.00
Bio-Techne Corp (TECH) United States $6.096B 41.18
Galapagos (GLPG) Belgium $5.286B 0.00
Alkermes (ALKS) Ireland $5.128B 3300.00
Exelixis (EXEL) United States $5.011B 14.20
Amarin (AMRN) Ireland $4.712B 0.00
Horizon Pharma Public (HZNP) Ireland $3.560B 14.65
Immunomedics (IMMU) United States $3.504B 0.00
MorphoSys AG Unsponsored ADR (MOR) Germany $3.454B 0.00
Emergent Biosolutions (EBS) United States $3.378B 28.46
Ligand Pharmaceuticals (LGND) United States $3.141B 24.03
Guardant Health (GH) United States $3.113B 0.00
Array BioPharma (ARRY) United States $3.096B 0.00
ARGENX SE-ADR (ARGX) Netherlands $2.973B 0.00
Allogene Therapeutics (ALLO) United States $2.881B 0.00
Intercept Pharmaceuticals (ICPT) United States $2.863B 0.00
Repligen (RGEN) United States $2.797B 87.37
Genomic Health (GHDX) United States $2.737B 92.39
Blueprint Medicines (BPMC) United States $2.466B 0.00
Ultragenyx Pharmaceutical (RARE) United States $2.447B 0.00
Akcea Therapeutics (AKCA) United States $2.408B 0.00
Ascendis Pharma (ASND) Denmark $2.357B 0.00
China Biologic Products (CBPO) China $2.315B 16.48
Acceleron Pharma (XLRN) United States $2.310B 0.00
Allakos (ALLK) United States $2.277B 0.00
Halozyme Therapeutics (HALO) United States $2.215B 49.42
Myriad Genetics (MYGN) United States $2.209B 21.89
ACADIA Pharmaceuticals (ACAD) United States $2.193B 0.00
MyoKardia (MYOK) United States $2.177B 0.00
REGENXBIO (RGNX) United States $2.115B 28.37
Amicus Therapeutics (FOLD) United States $1.938B 0.00
Global Blood Therapeutics (GBT) United States $1.876B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $1.804B 0.00
Reata Pharmaceuticals (RETA) United States $1.785B 0.00
AnaptysBio (ANAB) United States $1.735B 0.00
Aimmune Therapeutics (AIMT) United States $1.698B 0.00
Denali Therapeutics (DNLI) United States $1.661B 0.00
Innoviva (INVA) United States $1.638B 9.26
Arena Pharmaceuticals (ARNA) United States $1.607B 0.00
Cambrex (CBM) United States $1.604B 11.98
Atara Biotherapeutics (ATRA) United States $1.545B 0.00
Spark Therapeutics (ONCE) United States $1.540B 0.00
Medicines (MDCO) United States $1.536B 0.00
G1 THERAPEUTICS (GTHX) United States $1.503B 0.00
NeoGenomics (NEO) United States $1.488B 123.08
Rubius Therapeutics (RUBY) United States $1.460B 0.00
Autolus Therapeutics Sponsored ADR (AUTL) United Kingdom $1.435B 0.00
Biohaven Pharmaceutical Holding (BHVN) United States $1.352B 0.00
ORCHARD THERAPT (ORTX) United Kingdom $1.320B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $1.306B 0.00
Editas Medicine (EDIT) United States $1.286B 0.00
Insmed (INSM) United States $1.284B 0.00
Myovant Sciences (MYOV) United Kingdom $1.274B 0.00
Mirati Therapeutics (MRTX) United States $1.211B 0.00
Vanda Pharmaceuticals (VNDA) United States $1.172B 93.13
IMMURON LTD (IMRN) Australia $1.160B 0.00
WAVE Life Sciences (WVE) Singapore $1.129B 0.00
Lion Biotechnologies (IOVA) United States $1.084B 0.00
Solid Biosciences (SLDB) United States $1.057B 0.00
Cellectis (CLLS) France $1.015B 0.00
Momenta Pharmaceuticals (MNTA) United States $0.995B 0.00
Zai Lab Unsponsored ADR (ZLAB) China $0.984B 0.00
Sangamo Therapeutics (SGMO) United States $0.971B 0.00
Retrophin (RTRX) United States $0.968B 0.00
Audentes Therapeutics (BOLD) United States $0.960B 0.00
DBV Technologies (DBVT) France $0.934B 0.00
Rhythm Pharmaceuticals (RYTM) United States $0.913B 0.00
Acorda Therapeutics (ACOR) United States $0.885B 11.20
Alder BioPharmaceuticals (ALDR) United States $0.883B 0.00
Intra-Cellular Therapies (ITCI) United States $0.868B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.857B 0.00
UniQure (QURE) Netherlands $0.850B 0.00
Kiniksa Pharmaceuticals (KNSA) Bermuda $0.845B 0.00
Puma Biotechnology (PBYI) United States $0.837B 0.00
Aptinyx (APTX) United States $0.833B 0.00
Fate Therapeutics (FATE) United States $0.821B 0.00
Y-mAbs Therapeutics (YMAB) United States $0.820B 0.00
Dicerna Pharmaceuticals (DRNA) United States $0.804B 0.00
Clovis Oncology (CLVS) United States $0.795B 0.00
Viking Therapeutics (VKTX) United States $0.784B 0.00
Deciphera Pharmaceuticals (DCPH) United States $0.775B 0.00
Revance Therapeutics (RVNC) United States $0.771B 0.00
Apellis Pharmaceuticals (APLS) United States $0.769B 0.00
Heska (HSKA) United States $0.746B 61.09
Coherus BioSciences (CHRS) United States $0.746B 0.00
Intellia Therapeutics (NTLA) United States $0.739B 0.00
Dynavax Technologies (DVAX) United States $0.720B 0.00
Cara Therapeutics (CARA) United States $0.712B 0.00
AVROBIO (AVRO) United States $0.704B 0.00
Vericel (VCEL) United States $0.702B 0.00
InflaRx (IFRX) Germany $0.702B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.687B 0.00
Athenex (ATNX) United States $0.684B 0.00
TWIST BIOSCIENC (TWST) United States $0.654B 0.00
UROGEN PHARMA (URGN) Israel $0.654B 0.00
Novavax (NVAX) United States $0.639B 0.00
CytomX Therapeutics (CTMX) United States $0.620B 0.00
ANI Pharmaceuticals (ANIP) United States $0.616B 11.81
AMAG Pharmaceuticals (AMAG) United States $0.588B 0.00
AC Immune SA (ACIU) Switzerland $0.582B 0.00
NuCana Sponsored ADR (NCNA) United Kingdom $0.578B 0.00
Gritstone Oncology (GRTS) United States $0.576B 0.00
Epizyme (EPZM) United States $0.575B 0.00
Principia Biopharma (PRNB) United States $0.572B 0.00
Inotek Pharmaceuticals (RCKT) United States $0.567B 0.00
Scholar Rock Holding (SRRK) United States $0.558B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.533B 0.00
Arvinas (ARVN) United States $0.529B 0.00
Senesco Technologies (ELOX) United States $0.526B 0.00
UNITY Biotechnology (UBX) $0.510B 0.00
Eidos Therapeutics (EIDX) United States $0.505B 0.00
Arcus Biosciences (RCUS) United States $0.504B 0.00
Anika Therapeutics (ANIK) United States $0.503B 20.81
Kezar Life Sciences (KZR) United States $0.492B 0.00
ObsEva SA (OBSV) Switzerland $0.486B 0.00
BeyondSpring (BYSI) United States $0.483B 0.00
Clementia Pharmaceuticals (CMTA) Canada $0.468B 0.00
Inovio Pharmaceuticals (INO) United States $0.468B 0.00
Mesoblast (MESO) Australia $0.464B 0.00
Replimune (REPL) United States $0.444B 0.00
Prothena (PRTA) Ireland $0.440B 0.00
Kura Oncology (KURA) United States $0.434B 0.00
PDL BioPharma (PDLI) United States $0.425B 6.93
RA PHARMCTL INC (RARX) United States $0.421B 0.00
Sinovac Biotech (SVA) China $0.420B 0.00
Kindred Biosciences (KIN) United States $0.417B 0.00
MediciNova (MNOV) United States $0.412B 0.00
Zymeworks (ZYME) Canada $0.409B 0.00
Sorrento Therapeutics (SRNE) United States $0.402B 65.80
Five Prime Therapeutics (FPRX) United States $0.389B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.384B 0.00
Nightstar Therapeutics Sponsored ADR (NITE) United States $0.380B 0.00
Stemline Therapeutics (STML) United States $0.364B 0.00
Achillion Pharmaceuticals (ACHN) United States $0.363B 0.00
Osiris Therapeutics (OSIR) United States $0.361B 0.00
Abeona Therapeutics (ABEO) United States $0.360B 0.00
Zealand Pharma (ZEAL) Denmark $0.354B 0.00
Verastem (VSTM) United States $0.353B 0.00
Liquidia Technologies (LQDA) United States $0.343B 0.00
MeiraGTx Holdings (MGTX) United States $0.342B 0.00
Seres Therapeutics (MCRB) United States $0.338B 0.00
Cytokineticsorporated (CYTK) United States $0.338B 0.00
LogicBio Therapeutics (LOGC) United States $0.330B 0.00
ResTORbio (TORC) United States $0.329B 0.00
Kodiak Sciences (KOD) United States $0.316B 0.00
Krystal Biotech (KRYS) United States $0.313B 0.00
Merus (MRUS) Netherlands $0.306B 0.00
Cellular Biomedicine (CBMG) United States $0.304B 0.00
Albireo Pharma (ALBO) United States $0.299B 0.00
MannKind (MNKD) United States $0.284B 0.00
Biofrontera AG Sponsored ADR (BFRA) Germany $0.284B 0.00
Keryx Biopharmaceuticals (KERX) United States $0.283B 0.00
Geron (GERN) United States $0.281B 0.00
Kadmon Holdings (KDMN) United States $0.277B 0.00
Celyad SA (CYAD) Belgium $0.274B 0.00
Peregrine Pharmaceuticals (CDMO) United States $0.270B 0.00
Equillium (EQ) United States $0.266B 0.00
Sutro Biopharma (STRO) United States $0.265B 0.00
Aduro Biotech (ADRO) United States $0.264B 0.00
Celcuity (CELC) United States $0.261B 0.00
Athersys (ATHX) United States $0.259B 0.00
BioDelivery Sciences (BDSI) United States $0.253B 0.00
Syros Pharmaceuticals (SYRS) United States $0.252B 0.00
Agenus (AGEN) United States $0.247B 0.00
Arbutus Biopharma (ABUS) Canada $0.243B 0.00
Unum Therapeutics (UMRX) United States $0.240B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.239B 0.00
GAMIDA CELL LTD (GMDA) Israel $0.237B 0.00
TOCAGEN INC (TOCA) United States $0.237B 0.00
Evelo Biosciences (EVLO) United States $0.233B 0.00
Axovant Sciences (AXON) United Kingdom $0.232B 0.00
ADMA Biologics Inc (ADMA) United States $0.232B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.231B 0.00
BioTime (BTX) United States $0.229B 0.00
Strongbridge Biopharma (SBBP) United States $0.227B 0.00
Proteostasis Therapeutics (PTI) United States $0.225B 0.00
Adverum Biotechnologies (ADVM) United States $0.224B 0.00
Magenta Therapeutics (MGTA) United States $0.221B 0.00
Urovant Sciences (UROV) United States $0.217B 0.00
Kamada (KMDA) Israel $0.216B 19.83
Synlogic (SYBX) United States $0.215B 0.00
Kala Pharmaceuticals (KALA) United States $0.214B 0.00
Sienna Biopharmaceuticals (SNNA) United States $0.210B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.199B 0.00
Protagonist Therapeutics (PTGX) United States $0.197B 0.00
Idera Pharmaceuticals (IDRA) United States $0.195B 0.00
Intec Pharma (NTEC) Israel $0.191B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.188B 0.00
ChromaDex (CDXC) United States $0.187B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.179B 0.00
Eiger BioPharmaceuticals (EIGR) United States $0.177B 0.00
NantKwest (NK) United States $0.174B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.171B 0.00
Palatin Technologies (PTN) United States $0.169B 20.75
Compugen (CGEN) Israel $0.167B 0.00
Spring Bank Pharmaceuticals (SBPH) United States $0.165B 0.00
Allena Pharmaceuticals (ALNA) United States $0.164B 0.00
Cerecor (CERC) United States $0.157B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.155B 0.00
PSivida (EYPT) United States $0.153B 0.00
Pfenex (PFNX) United States $0.149B 0.00
Menlo Therapeutics (MNLO) United States $0.149B 0.00
Constellation Pharmaceuticals (CNST) United States $0.149B 0.00
Enzo Biochem (ENZ) United States $0.148B 0.00
Mersana Therapeutics (MRSN) United States $0.146B 0.00
Verona Pharma American Depositary Share (VRNA) United Kingdom $0.145B 0.00
XBiotech (XBIT) United States $0.145B 0.00
Erytech Pharma SA Sponsored ADR (ERYP) France $0.144B 0.00
Spero Therapeutics (SPRO) United States $0.143B 0.00
Cohbar (CWBR) United States $0.138B 0.00
Pluristem Therapeutics (PSTI) Israel $0.133B 0.00
Organovo Holdings (ONVO) United States $0.127B 0.00
Selecta Biosciences (SELB) United States $0.127B 0.00
Eleven Biotherapeutics (SESN) United States $0.124B 0.00
Applied Genetic Technologies (AGTC) United States $0.124B 0.00
Catalyst Biosciences (CBIO) United States $0.123B 0.00
VBI Vaccines (VBIV) United States $0.120B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.120B 0.00
Cue Biopharma (CUE) United States $0.115B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.114B 0.00
CorMedix Inc (CRMD) United States $0.114B 0.00
XOMA (XOMA) United States $0.112B 0.00
OVID THERAPEUTC (OVID) United States $0.112B 0.00
Anavex Life Sciences (AVXL) United States $0.110B 0.00
Motif Bio Plc (MTFB) United States $0.109B 0.00
Mustang Bio (MBIO) United States $0.109B 0.00
Signal Genetics (MGEN) United States $0.108B 0.00
Cidara Therapeutics (CDTX) United States $0.107B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.101B 0.00
Provention Bio (PRVB) United States $0.098B 0.00
Chiasma (CHMA) United States $0.098B 0.00
ScPharmaceuticals (SCPH) United States $0.095B 0.00
Orgenesis (ORGS) United States $0.090B 0.00
PHASEBIO PHARMA (PHAS) United States $0.088B 0.00
Neothetics (EVFM) United States $0.088B 0.00
Axsome Therapeutics (AXSM) United States $0.084B 0.00
BioXcel Therapeutics (BTAI) United States $0.083B 0.00
Cocrystal Pharma (COCP) United States $0.082B 91.00
Ophthotech (OPHT) United States $0.079B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.079B 0.00
VolitionRX (VNRX) Singapore $0.077B 0.00
Checkpoint Therapeutics (CKPT) United States $0.077B 0.00
Monster Digital (INNT) United States $0.076B 0.00
Prima BioMed (IMMP) Australia $0.076B 0.00
Cel-Sci (CVM) United States $0.075B 0.00
Aptose Biosciences (APTO) Canada $0.074B 0.00
Vaccinex (VCNX) United States $0.072B 0.00
Aptevo Therapeutics (APVO) United States $0.070B 0.00
Bionano Genomics (BNGO) United States $0.070B 0.00
Alimera Sciences (ALIM) United States $0.070B 0.00
Versartis (ARAV) United States $0.070B 6.12
Evogene (EVGN) Israel $0.069B 0.00
NewLink Genetics (NLNK) United States $0.069B 0.00
VTv Therapeutics (VTVT) United States $0.069B 0.00
ITUS (ANIX) United States $0.067B 0.00
Asterias Biotherapeutics (AST) United States $0.067B 0.00
Alcobra (ARCT) United States $0.066B 0.00
Brainstorm Cell Therapeutics (BCLI) United States $0.064B 0.00
Protalix BioTherapeutics (PLX) Israel $0.063B 0.00
Merrimack Pharmaceuticals (MACK) United States $0.061B 0.00
VistaGen Therapeutics (VTGN) United States $0.060B 0.00
Entera Bio (ENTX) Israel $0.059B 0.00
Fortress Biotech (FBIO) United States $0.058B 0.00
Celldex Therapeutics (CLDX) United States $0.057B 0.00
OncoMed Pharmaceuticals (OMED) United States $0.056B 9.00
Bellerophon Therapeutics (BLPH) United States $0.055B 0.00
Sophiris Bio (SPHS) United States $0.055B 0.00
Leap Therapeutics (LPTX) United States $0.053B 0.00
Oncobiologics (ONS) United States $0.053B 0.00
Trevena (TRVN) United States $0.052B 0.00
OncoSec Medical (ONCS) United States $0.049B 0.00
Caladrius Biosciences (CLBS) United States $0.049B 0.00
Clearside Biomedical (CLSD) United States $0.048B 0.00
Curis (CRIS) United States $0.047B 0.00
Oncolytics Biotech (ONCY) Canada $0.047B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.045B 0.00
Zosano Pharma (ZSAN) United States $0.045B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.043B 0.00
Vascular Biogenics (VBLT) Israel $0.043B 0.00
Rexahn Pharmaceuticals (RNN) United States $0.041B 0.00
AEterna Zentaris (AEZS) United States $0.040B 7.59
TRACON Pharmaceuticals (TCON) United States $0.039B 0.00
AquaBounty Technologies (AQB) United States $0.039B 0.00
Galena Biopharma (SLS) United States $0.038B 0.00
BiondVax Pharmaceuticals (BVXV) Israel $0.037B 0.00
Celsion (CLSN) United States $0.037B 0.00
AZURRX BIOPHARM (AZRX) United States $0.036B 0.00
Moleculin Biotech (MBRX) United States $0.034B 0.00
BioPharmX (BPMX) United States $0.034B 0.00
VIVUS (VVUS) United States $0.034B 0.00
GTx (GTXI) United States $0.034B 0.00
Aileron Therapeutics (ALRN) United States $0.033B 0.00
Eyenovia (EYEN) United States $0.031B 0.00
Proteon Therapeutics (PRTO) United States $0.030B 0.00
Therapix Biosciences (TRPX) Israel $0.028B 10.27
Vical (VICL) United States $0.027B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.026B 0.00
Advaxis (ADXS) United States $0.026B 0.00
Benitec Biopharma (BNTC) Australia $0.025B 0.00
OvaScience (OVAS) United States $0.024B 0.00
Cellect Biotechnology (APOP) Israel $0.024B 0.00
CytRx (CYTR) United States $0.022B 0.00
Edge Therapeutics (EDGE) United States $0.021B 0.00
Novelion Therapeutics (NVLN) Canada $0.020B 0.00
GENPREX INC (GNPX) United States $0.020B 0.00
Pulmatrix (PULM) United States $0.019B 0.00
Cleveland BioLabs (CBLI) United States $0.019B 0.00
Fibrocell Science Inc (FCSC) United States $0.019B 0.00
Genetic Technologies (GENE) Australia $0.019B 0.00
Gemphire Therapeutics (GEMP) United States $0.018B 0.00
Arsanis (ASNS) United States $0.017B 0.00
TrovaGene (TROV) United States $0.017B 0.00
Soligenix (SNGX) United States $0.017B 0.00
RestorGenex (DFFN) United States $0.016B 0.00
Prana Biotechnology (PRAN) Australia $0.016B 0.00
ATyr Pharma (LIFE) United States $0.016B 0.00
IBio (IBIO) United States $0.014B 0.00
Vital Therapies (VTL) United States $0.013B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.013B 0.00
Novogen (KZIA) Australia $0.013B 0.00
Histogenics (HSGX) United States $0.012B 0.00
Cerulean Pharma (DARE) United States $0.011B 0.00
Hemispherx BioPharma (HEB) United States $0.010B 0.00
Titan Pharmaceuticals (TTNP) United States $0.010B 0.00
Oragenics (OGEN) United States $0.010B 0.00
ARCA Biopharma (ABIO) United States $0.009B 0.00
Aytu Bioscience (AYTU) United States $0.009B 0.00
Alliqua BioMedical (ALQA) United States $0.009B 0.00
Flex Pharma (FLKS) United States $0.009B 0.00
AmpliPhi Biosciences (APHB) United States $0.008B 0.00
Adial Pharmaceuticals (ADIL) United States $0.008B 0.00
MYOS RENS Technology (MYOS) United States $0.008B 0.00
Neuralstem (CUR) United States $0.008B 0.00
ContraVir Pharmaceuticals Inc (CTRV) United States $0.007B 0.00
Tenax Therapeutics (TENX) United States $0.006B 0.00
Synthetic Biologics (SYN) United States $0.006B 0.00
Stellar Biotechnologies (SBOT) United States $0.005B 0.00
Cytori Therapeutics Inc (CYTX) United States $0.003B 0.00
OSMOTICA PHARM (OSMT) United States $0.000B 0.00